• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

药物过度使用性偏头痛患者疼痛干扰和头痛影响的决定因素:MOTS 试验结果。

Determinants of pain interference and headache impact in patients who have chronic migraine with medication overuse: Results from the MOTS trial.

机构信息

Mayo Clinic, Department of Neurology, Phoenix, AZ, USA.

University of Southern California, Department of Neurology, Los Angeles, CA, USA.

出版信息

Cephalalgia. 2021 Sep;41(10):1053-1064. doi: 10.1177/03331024211006903. Epub 2021 May 2.

DOI:10.1177/03331024211006903
PMID:33938249
Abstract

OBJECTIVE

"Pain interference" and "headache impact" refer to negative consequences that pain and headache have on one's life. This study investigated determinants of these negative impacts in a large patient cohort who have chronic migraine with medication overuse.

METHODS

Six hundred and eleven adults were enrolled from 34 headache, neurology, and primary care clinics. Negative consequences of chronic migraine with medication overuse were determined using the Patient-Reported Outcomes Measurement Information System (PROMIS) Pain Interference 6b questionnaire and the Headache Impact Test 6. Relationships between PROMIS-6b and Headache Impact Test 6 scores with demographics, headache characteristics, medication use, anxiety symptoms, and depression symptoms were assessed with linear regression. Elastic Net regression was used to develop a multiple regression model.

RESULTS

PROMIS-6b T-Scores averaged 65.2 (SD 5.4) and Headache Impact Test 6 scores averaged 65.0 (SD 5.3), indicating severe negative consequences of chronic migraine with medication overuse. Chronic migraine with medication overuse interfered with enjoyment of life, concentration, daily activities, doing tasks away from home, and socializing. Depression symptom severity had the strongest relationship with pain interference and headache impact. Moderate-to-severe headache frequency, headache intensity, and anxiety symptoms were also associated with pain interference and headache impact.

CONCLUSIONS

Chronic migraine with medication overuse is associated with substantial negative consequences, the extent of which is most strongly related to depression symptoms.

摘要

目的

“疼痛干扰”和“头痛影响”是指疼痛和头痛对生活造成的负面影响。本研究调查了患有药物过度使用性慢性偏头痛的大量患者群体中这些负面影响的决定因素。

方法

从 34 家头痛、神经病学和初级保健诊所招募了 611 名成年人。使用患者报告的结果测量信息系统(PROMIS)疼痛干扰 6b 问卷和头痛影响测试 6 来确定药物过度使用性慢性偏头痛的负面后果。使用线性回归评估 PROMIS-6b 和头痛影响测试 6 评分与人口统计学、头痛特征、药物使用、焦虑症状和抑郁症状之间的关系。使用弹性网络回归开发多回归模型。

结果

PROMIS-6b T 评分平均为 65.2(SD 5.4),头痛影响测试 6 评分平均为 65.0(SD 5.3),表明药物过度使用性慢性偏头痛的严重负面影响。药物过度使用性慢性偏头痛干扰了生活乐趣、注意力、日常活动、离家活动和社交。抑郁症状严重程度与疼痛干扰和头痛影响的关系最强。中度至重度头痛频率、头痛强度和焦虑症状也与疼痛干扰和头痛影响有关。

结论

药物过度使用性慢性偏头痛与严重的负面影响相关,其程度与抑郁症状最相关。

相似文献

1
Determinants of pain interference and headache impact in patients who have chronic migraine with medication overuse: Results from the MOTS trial.药物过度使用性偏头痛患者疼痛干扰和头痛影响的决定因素:MOTS 试验结果。
Cephalalgia. 2021 Sep;41(10):1053-1064. doi: 10.1177/03331024211006903. Epub 2021 May 2.
2
Functional impairment of chronic migraine with medication overuse: Secondary analysis from the Medication Overuse Treatment Strategy (MOTS) trial.慢性偏头痛伴药物过度使用的功能障碍:药物过度使用治疗策略(MOTS)试验的二次分析。
Headache. 2024 Jun;64(6):632-642. doi: 10.1111/head.14732. Epub 2024 May 23.
3
Headache characteristics and burden from chronic migraine with medication overuse headache: Cross-sectional observations from the Medication Overuse Treatment Strategy trial.慢性偏头痛伴药物过量使用性头痛的头痛特征与负担:药物过量使用治疗策略试验的横断面观察结果
Headache. 2021 Feb;61(2):351-362. doi: 10.1111/head.14056. Epub 2021 Jan 12.
4
Patient-Centered Treatment of Chronic Migraine With Medication Overuse: A Prospective, Randomized, Pragmatic Clinical Trial.以患者为中心的药物过度使用性慢性偏头痛治疗:一项前瞻性、随机、实用的临床试验。
Neurology. 2022 Apr 5;98(14):e1409-e1421. doi: 10.1212/WNL.0000000000200117. Epub 2022 Feb 15.
5
Medication use in patients with migraine and medication-overuse headache: the role of problem-solving and attitudes about pain medication.偏头痛和药物过度使用性头痛患者的用药情况:解决问题的方法和对疼痛药物的态度的作用。
Pain. 2011 Jun;152(6):1334-1339. doi: 10.1016/j.pain.2011.02.014. Epub 2011 Mar 10.
6
Prevalence of medication overuse headache in an interdisciplinary pain clinic.跨学科疼痛诊所中药物过度使用性头痛的患病率。
J Headache Pain. 2013 Jan 30;14(1):4. doi: 10.1186/1129-2377-14-4.
7
Medication overuse headache: Updating of the French recommendations regarding the treatment strategies.药物过度使用性头痛:治疗策略法国推荐的更新。
Rev Neurol (Paris). 2021 Sep;177(7):760-764. doi: 10.1016/j.neurol.2021.07.003. Epub 2021 Jul 28.
8
Factors associated with acute medication overuse in people with migraine: results from the 2017 migraine in America symptoms and treatment (MAST) study.与偏头痛患者急性药物过度使用相关的因素:来自 2017 年美国偏头痛症状和治疗(MAST)研究的结果。
J Headache Pain. 2018 May 24;19(1):38. doi: 10.1186/s10194-018-0865-z.
9
The burden of medication overuse headache and patterns of switching and discontinuation among triptan users: a systematic literature review.药物过度使用性头痛的负担以及曲坦类药物使用者的转换和停药模式:系统文献回顾。
BMC Neurol. 2021 Nov 2;21(1):425. doi: 10.1186/s12883-021-02451-x.
10
The heterogeneity of headache patients who self-medicate: a cluster analysis approach.自行用药的头痛患者的异质性:一种聚类分析方法。
Pain. 2016 Jul;157(7):1464-1471. doi: 10.1097/j.pain.0000000000000541.

引用本文的文献

1
The Comprehensive Effect of Depression, Anxiety, and Headache on Pain Intensity and Painkiller Use in Patients with Headache Analyzed by Unsupervised Clustering Using Machine Learning.通过机器学习无监督聚类分析抑郁症、焦虑症和头痛对头痛患者疼痛强度和止痛药使用的综合影响
Biomedicines. 2025 May 30;13(6):1345. doi: 10.3390/biomedicines13061345.
2
The relationship between abnormal glucose metabolism and chronic pain.异常糖代谢与慢性疼痛之间的关系。
Cell Biosci. 2025 Jun 21;15(1):86. doi: 10.1186/s13578-025-01430-w.
3
Efficacy and Safety of Erenumab for Nonopioid Medication Overuse Headache in Chronic Migraine: A Phase 4, Randomized, Placebo-Controlled Trial.
erenumab治疗慢性偏头痛中非阿片类药物过度使用性头痛的疗效和安全性:一项4期随机安慰剂对照试验
JAMA Neurol. 2024 Sep 16;81(11):1140-9. doi: 10.1001/jamaneurol.2024.3043.
4
Potential predictors for the efficacy of non-steroidal anti-inflammatory drugs in patients with migraine.偏头痛患者使用非甾体抗炎药疗效的潜在预测因素。
Saudi Pharm J. 2023 May;31(5):692-697. doi: 10.1016/j.jsps.2023.03.010. Epub 2023 Mar 21.
5
Prediction and associated factors of non-steroidal anti-inflammatory drugs efficacy in migraine treatment.偏头痛治疗中非甾体抗炎药疗效的预测及相关因素
Front Pharmacol. 2022 Nov 18;13:1002080. doi: 10.3389/fphar.2022.1002080. eCollection 2022.